Gene · 9972
Papers1,505
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,505
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| A cellular atlas of calcineurin signaling. | Biochim Biophys Acta Mol Cell Res | 2023 | 36191737 | PubTator, text mining | PubMed |
| Identifying and validating molecular subtypes of biliary atresia using multiple high-throughput data integration analysis. | Front Immunol | 2022 | 36713418 | PubTator, text mining | PubMed |
| The diverse roles of miRNAs in HIV pathogenesis: Current understanding and future perspectives. | Front Immunol | 2022 | 36685589 | PubTator, text mining | PubMed |
| Determinants of Retroviral Integration and Implications for Gene Therapeutic MLV-Based Vectors and for a Cure for HIV-1 Infection. | Viruses | 2022 | 36680071 | PubTator, text mining | PubMed |
| Nuclear pore complexes concentrate on Actin/LINC/Lamin nuclear lines in response to mechanical stress in a SUN1 dependent manner. | Heliyon | 2022 | 36619427 | PubTator, text mining | PubMed |
| Nuclear envelope, chromatin organizers, histones, and DNA: The many achilles heels exploited across cancers. | Front Cell Dev Biol | 2022 | 36589746 | PubTator, text mining | PubMed |
| 53BP1: Keeping It under Control, Even at a Distance from DNA Damage. | Genes (Basel) | 2022 | 36553657 | PubTator, text mining | PubMed |
| A Combined Risk Score Model to Assess Prognostic Value in Patients with Soft Tissue Sarcomas. | Cells | 2022 | 36552841 | PubTator, text mining | PubMed |
| HCC biomarkers - state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice. | Front Oncol | 2022 | 36518320 | PubTator, text mining | PubMed |
| Cardiovirus leader proteins retarget RSK kinases toward alternative substrates to perturb nucleocytoplasmic traffic. | PLoS Pathog | 2022 | 36508477 | PubTator, text mining | PubMed |
| Pore performance: artificial nanoscale constructs that mimic the biomolecular transport of the nuclear pore complex. | Nanoscale Adv | 2022 | 36504753 | PubTator, text mining | PubMed |
| Discovery and Mechanistic Investigation of Piperazinone Phenylalanine Derivatives with Terminal Indole or Benzene Ring as Novel HIV-1 Capsid Modulators. | Molecules | 2022 | 36500508 | PubTator, text mining | PubMed |
| The microRNA Lifecycle in Health and Cancer. | Cancers (Basel) | 2022 | 36497229 | PubTator, text mining | PubMed |
| Nuclear import receptors are recruited by FG-nucleoporins to rescue hallmarks of TDP-43 proteinopathy. | Mol Neurodegener | 2022 | 36482422 | PubTator, text mining | PubMed |
| Tough Way In, Tough Way Out: The Complex Interplay of Host and Viral Factors in Nucleocytoplasmic Trafficking during HIV-1 Infection. | Viruses | 2022 | 36423112 | PubTator, text mining | PubMed |
| Evaluation of HIV-1 capsid genetic variability and lenacapavir (GS-6207) drug resistance-associated mutations according to viral clades among drug-naive individuals. | J Antimicrob Chemother | 2022 | 36411257 | PubTator, text mining | PubMed |
| Design, Synthesis, and Mechanistic Study of 2-Pyridone-Bearing Phenylalanine Derivatives as Novel HIV Capsid Modulators. | Molecules | 2022 | 36364467 | PubTator, text mining | PubMed |
| Nuclear Membrane Protein SUN5 Is Highly Expressed and Promotes Proliferation and Migration in Colorectal Cancer by Regulating the ERK Pathway. | Cancers (Basel) | 2022 | 36358787 | PubTator, text mining | PubMed |
| NADPH Oxidase 5 (NOX5) Overexpression Promotes Endothelial Dysfunction via Cell Apoptosis, Migration, and Metabolic Alterations in Human Brain Microvascular Endothelial Cells (hCMEC/D3). | Antioxidants (Basel) | 2022 | 36358519 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9972/papers?page=9